marcellomycin has been researched along with epirubicin in 1 studies
Studies (marcellomycin) | Trials (marcellomycin) | Recent Studies (post-2010) (marcellomycin) | Studies (epirubicin) | Trials (epirubicin) | Recent Studies (post-2010) (epirubicin) |
---|---|---|---|---|---|
31 | 0 | 0 | 5,453 | 1,838 | 1,570 |
Protein | Taxonomy | marcellomycin (IC50) | epirubicin (IC50) |
---|---|---|---|
Genome polyprotein | 0.75 | ||
Tyrosine-protein kinase Fyn | Homo sapiens (human) | 5.181 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ogawa, M | 1 |
1 review(s) available for marcellomycin and epirubicin
Article | Year |
---|---|
[Current status of clinical results of new antitumor drugs].
Topics: Aminoacridines; Amsacrine; Anthracyclines; Anthraquinones; Antibiotics, Antineoplastic; Antineoplastic Agents; Aziridines; Benzoquinones; Carboplatin; Carubicin; Cisplatin; Daunorubicin; Doxorubicin; Eflornithine; Epirubicin; Humans; Idarubicin; Mitoxantrone; Naphthacenes; Neoplasms; Organoplatinum Compounds; Ornithine; Ribavirin | 1985 |